Advertisement DW Healthcare sells Tandem Labs to LabCorp - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

DW Healthcare sells Tandem Labs to LabCorp

Healthcare focused private equity firm DW Healthcare Partners has sold of one of its portfolio companies, Tandem Labs, to Laboratory Corporation of America Holdings or LabCorp.

Tandem Labs is a bioanalytical and immunoanalytical contract research organization (CRO) supporting pharmaceutical and biotechnology companies with their discovery, preclinical, and clinical drug development programs.

The sale of Tandem Labs generated approximately a return of 6.9 times the invested capital for DW Healthcare’s investors.